Semaglutide for weight loss in adults with HIV
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial studies whether semaglutide (a diabetes-type weight-loss injection) helps adults with HIV lose weight. It also checks that it’s safe for people whose HIV is well controlled on regular treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- You have HIV-1 and your viral load has been well controlled (under 40 copies/mL) for at least 2 years
- Your CD4 count is at least 200 for at least 1 year
- Your BMI is in the obesity range (BMI 30+, or BMI 27+ if you also have conditions like high blood pressure, high cholesterol, or type 2 diabetes)
- You can follow the study plan and agree to it in writing
- You are able to inject semaglutide under the skin yourself (or with help that the study allows)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests a nasal spray containing semaglutide (a GLP-1 receptor agonist) to see if it helps adults who are overweight or obese lose weight. It may be an option if you have a BMI between 27 and 35 and have not used other weight loss medications recently.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This trial tests a medicine called semaglutide (often used for diabetes) to see if it helps people in Bangladesh who are overweight or obese lose weight. The study will check if the medicine is safe and effective for both people with and without type 2 diabetes.
This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.